pharmaphorum
OCTOBER 6, 2020
An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports. The issue that left almost 16,000 positive results going unreported has been blamed on the way Public Health England tracks results from mainly private labs that have been hired to add extra testing capacity.
Drug Patent Watch
OCTOBER 6, 2020
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…. The post Finding and Evaluating Generic Drug Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
OCTOBER 8, 2020
A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.
NY Times
OCTOBER 8, 2020
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
OCTOBER 5, 2020
Digital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer health giant Reckitt Benckiser (RB). Your.MD is the company behind the medical-grade, augmented intelligence self-care app Healthily, and will use the funding to accelerate the platform through a series of clinically-validated “health hubs”. Following a seed funding round led by RB and existing shareholders, the now completed Series A funding round will allow the app to reach other markets incl
Drug Patent Watch
OCTOBER 9, 2020
Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents…. The post New patent expiration for Leo Labs drug PICATO appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
OCTOBER 4, 2020
Many of the measures cited by his doctors are reserved for patients severely affected by the coronavirus.
pharmaphorum
OCTOBER 8, 2020
A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future. As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP UK & Ireland and general manager for the UK at GSK, tells us that it is “absolutely critical” to do this with the pace and out-of-the box thinking of the past months.
Pharma Marketing Network
OCTOBER 5, 2020
An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.
Pharma Times
OCTOBER 5, 2020
Combination treatment did not achieve statistical significance in all-comer population
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
OCTOBER 6, 2020
A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.
pharmaphorum
OCTOBER 5, 2020
As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. According to weekend press reports a rollout of a vaccine could be just three months away – but the feedback from the government is that not everyone will get it, with the target group being around 30 million older people and health workers, less than half the p
Pharma Marketing Network
OCTOBER 5, 2020
An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.
Pharma Times
OCTOBER 6, 2020
Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen
Outsourcing Pharma
OCTOBER 7, 2020
The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.
pharmaphorum
OCTOBER 9, 2020
Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government. The findings came from additional safety and efficacy data harvested from the US National Institute of Allergy and Infectious Diseases’ (NIAID) ACCT-2 trial.
Pharma Marketing Network
OCTOBER 9, 2020
Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.
Pharma Times
OCTOBER 8, 2020
New agreement allows countries in the EU, EEA and the UK to purchase drug
NY Times
OCTOBER 3, 2020
Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.
pharmaphorum
OCTOBER 9, 2020
Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study hopes to kick start a revolution in understanding. For five years, Michelle Erskine faced a succession of closed doors and disbelief as she struggled to convince someone that all was not well with her son.
Outsourcing Pharma
OCTOBER 5, 2020
Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.
Pharma Times
OCTOBER 7, 2020
Biosimilar is an anti-VEGF therapy for retinal vascular disorders
NY Times
OCTOBER 3, 2020
No patients were affected, but the incident was another reminder of the risks in the increasingly common assaults on computer networks.
pharmaphorum
OCTOBER 9, 2020
The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johnson’s experimental candidate. The agreement is the third for coronavirus vaccine supply for the EU, coming after earlier deals with AstraZeneca and Sanofi/GlaxoSmithKline, and comes as wealthy nations are scrambling to secure access to the initial supplies of the shots furthest ahead in development.
Outsourcing Pharma
OCTOBER 8, 2020
eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.
Pharma Times
OCTOBER 7, 2020
Potential disease modifying osteoarthritis candidate is phase II ready
Pharma Mirror
OCTOBER 6, 2020
One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as cell sorting or cell separation, the cell isolation method has rapidly become an integral component of modern biological and medical research. In this method, a one-cell population or multiple cell types are isolated from a. The post How is Cell Isolation Revolutionizing Medical Industry?
pharmaphorum
OCTOBER 8, 2020
Eli Lilly has asked the FDA for an Emergency Use Authorization for its COVID-19 antibody therapy, after announcing new efficacy data from an ongoing trial. It’s been a big week for this class of therapies – Regeneron’s antibody cocktail was famously used to treat president Donald Trump’s illness and GlaxoSmithKline is expanding research into its rival.
NY Times
OCTOBER 4, 2020
Speed and scale may matter more than absolute effectiveness when it comes to tests, masks, treatments and vaccines.
Pharma Times
OCTOBER 9, 2020
Fadraciclib has passed safety trials and shown early efficacy
Pharma Marketing Network
OCTOBER 9, 2020
Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.
pharmaphorum
OCTOBER 7, 2020
Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently at the Max Planck Unit for the Science of Pathogens in Germany – and Doudna of the University of California, Berkeley (pictured left to right), are the first two women to share the prize awarded by the Royal Swedish Academy of Sciences.
NY Times
OCTOBER 6, 2020
She took on the drug and hospital industry as California attorney general, seeking consumer relief from anti-competitive pricing.
Pharma Times
OCTOBER 5, 2020
Gene therapy demonstrated improvement in retinal sensitivity
Drug Channels
OCTOBER 9, 2020
Today’s guest post comes from Shannon Stephenson, CEO of Cempa Community Care. I am publishing this opinion piece to share a perspective from a community health provider that is eligible for the 340B Drug Pricing Program as a Ryan White clinic and as a Federally Qualified Health Center Look-Alike. As I noted last week in my September news roundup , I generally consider federal grantees to be the good guys of 340B.
Expert insights. Personalized for you.
126 
Let's personalize your content